Clinical trial
Stem Cell Study for Patients With Heart Disease
NCT00221182 · Foundation for Biomedical Research and Innovation, Other · Terminated
Key facts
| NCT number | NCT00221182 |
|---|---|
| Title | Stem Cell Study for Patients With Heart Disease |
| Official title | Phase I / II Clinical Trial Regarding Vascular Regeneration Therapy by Transplantation of Autologous Peripheral Blood Endothelial Progenitor Cells (CD34+ Cells) in No-Option Patients With Chronic Myocardial Ischemia |
| Lead sponsor | Foundation for Biomedical Research and Innovation, Other |
| Collaborators | Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japan Kobe City General Hospital Okayama University School of Medicine |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Chest Pain, Chronic Myocardial Ischemia, Coronary Artery Disease, Angina, Myocardial Infarction |
| Intervention type | Genetic |
| Interventions | Autologous peripheral blood CD34 positive cell therapy |
| Enrollment | 1 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 22, 2011 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: